Nyhetsartiklar inom ämnet: navamedic

• Torsdag den 31 oktober

  07:00
• 07:00 Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business

• Fredag den 16 augusti

  07:00
• 07:01 Navamedic Q2 och H1 2024: Den stabila tillväxten fortsätter och stöds av ett nytt licensavtal
• 07:01 Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement

• Måndag den 6 maj

  11:00
• 11:02 Navamedic ASA: Broad launch for Eroxon® in Sweden today

• Torsdag den 15 februari

  08:00
• 08:03 Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives